Kuo-Sin Lin
Overview
Explore the profile of Kuo-Sin Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin C, Tseng S, Lu P, Chen T, Lin W, Chen Y, et al.
Transfusion
. 2011 Mar;
51(9):2023-7.
PMID: 21392018
Background: Bacterial contamination of platelet (PLT) products is one of the most serious complications of transfusion. Culturing PLT components may detect the presence of bacteria, thus reducing the risk of...
2.
Kee K, Hung C, Wang J, Hung C, Chen P, Lin K, et al.
J Gastroenterol Hepatol
. 2010 Jul;
25(7):1289-94.
PMID: 20594258
Background And Aim: This study attempted to clarify accuracy of acute hepatitis C (AHC) and its clinical characteristics. Methods: We reviewed 632 reported cases from national surveillance data of the...
3.
Pai S, Lo S, Lin Tsai S, Chang J, Lin D, Lin K, et al.
Transfusion
. 2010 May;
50(11):2318-27.
PMID: 20497513
Background: For HLA-alloimmunized patients, platelet (PLT) concentrations are provided either at matched HLA-A and HLA-B loci or by serologic cross-reactivity groups (CREG) matching strategy. However, this method has some limitations....
4.
Yang Y, Lin S, Chen J, Lin S, Yu S, Chen H, et al.
Leuk Res
. 2010 Jan;
34(1):18-23.
PMID: 20109966
Improved treatment of childhood acute lymphoblastic leukemia (ALL) depends on the identification of new molecular markers that are able to predict treatment response and clinical outcome. The development of impaired...
5.
Yang Y, Lin D, Chang S, Lin S, Lin S, Chiou R, et al.
Pediatr Blood Cancer
. 2009 Sep;
54(2):206-11.
PMID: 19774638
Objectives: This retrospective study evaluates the role of pharmacogenomic determinants in the treatment of childhood acute lymphoblastic leukemia (ALL) in the Taiwanese population. Methods: A total of 105 childhood ALL...
6.
Yang M, Li L, Hung Y, Hung C, Allain J, Lin K, et al.
Transfusion
. 2009 Aug;
50(1):65-74.
PMID: 19709394
Background: Financial constraints are the main concern in implementing nucleic acid testing (NAT) as routine blood screening in Taiwan. The PROCLEIX ULTRIO assay (Ultrio) on the TIGRIS System (Novartis Diagnostics)...
7.
Li L, Chen P, Chen M, Chak K, Lin K, Lin Tsai S
Transfusion
. 2008 Apr;
48(6):1198-206.
PMID: 18422856
Background: Blood donors in Taiwan currently are screened for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infection by immunoassay. The risk of enzyme immunoassay...
8.
Li L, Yang M, Chak K, Lin P, Lai C, Lin K, et al.
Transfusion
. 2007 May;
47(6):1014-21.
PMID: 17524091
Background: It was estimated that approximately 25 percent of Taiwanese residents were ABO blood group A. Many subgroups of A, however, revealed ambiguous serologic typing results. This study aimed to...
9.
Chern J, Lin K, Lu M, Lin D, Jou S, Yang Y, et al.
Pediatr Blood Cancer
. 2007 Apr;
50(1):58-61.
PMID: 17427230
Objective: A National Thalassemia Screening Program was adopted in Taiwan in 1993. This report examined that program's results and impact. Methods: Patients with beta-thalassemia major born between 1994 and 2003...
10.
Chern J, Su S, Lin K, Chang S, Lu M, Jou S, et al.
Pediatr Blood Cancer
. 2006 Sep;
48(5):550-4.
PMID: 16972241
Background: Advances in treatment have improved the prognosis in beta-thalassemia major. We present the survival and complications pattern of those patients in northern Taiwan born after 1970. Procedure: One-hundred and...